Δ15,18‐Tetracosadienoic acid content of sphingolipids from platelets and erythrocytes of animals fed diets high in saturated or polyunsaturated fats

Abstract

LipidsVolume 13, Issue 9 p. 626-626 ErratumFree Access Δ15,18-Tetracosadienoic acid content of sphingolipids from platelets and erythrocytes of animals fed diets high in saturated or polyunsaturated fats This article corrects the following: Δ15, 18-tetracosadienoic acid content of sphingolipids from platel and erythrocytes of animals fed diets high in saturated or polyunsaturated fats R. E. Pitas, G. J. Nelson, R. M. Jaffe, R. W. Mahley, Volume 13Issue 8Lipids pages: 551-556 First Published online: August 1, 1978 Dr. R. E. Pitas, Dr. R. E. Pitas Laboratory of Experimental Atheroslerosis, National Heart, Lung, and Blood Institute and Clinical Pathology Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, 20014 Division of Blood Diseases and Resources, National Heart, Lung, and Blood Institute and Clinical Pathology Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, 20014 Meloy Laboratories Inc., 6715 Electronic Drive, Springfield, VA, 22151Search for more papers by this authorG. J. Nelson, G. J. Nelson Laboratory of Experimental Atheroslerosis, National Heart, Lung, and Blood Institute and Clinical Pathology Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, 20014 Division of Blood Diseases and Resources, National Heart, Lung, and Blood Institute and Clinical Pathology Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, 20014 Meloy Laboratories Inc., 6715 Electronic Drive, Springfield, VA, 22151Search for more papers by this authorR. M. Jaffe, R. M. Jaffe Laboratory of Experimental Atheroslerosis, National Heart, Lung, and Blood Institute and Clinical Pathology Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, 20014 Division of Blood Diseases and Resources, National Heart, Lung, and Blood Institute and Clinical Pathology Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, 20014 Meloy Laboratories Inc., 6715 Electronic Drive, Springfield, VA, 22151Search for more papers by this authorR. W. Mahley, R. W. Mahley Laboratory of Experimental Atheroslerosis, National Heart, Lung, and Blood Institute and Clinical Pathology Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, 20014 Division of Blood Diseases and Resources, National Heart, Lung, and Blood Institute and Clinical Pathology Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, 20014 Meloy Laboratories Inc., 6715 Electronic Drive, Springfield, VA, 22151Search for more papers by this author Dr. R. E. Pitas, Dr. R. E. Pitas Laboratory of Experimental Atheroslerosis, National Heart, Lung, and Blood Institute and Clinical Pathology Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, 20014 Division of Blood Diseases and Resources, National Heart, Lung, and Blood Institute and Clinical Pathology Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, 20014 Meloy Laboratories Inc., 6715 Electronic Drive, Springfield, VA, 22151Search for more papers by this authorG. J. Nelson, G. J. Nelson Laboratory of Experimental Atheroslerosis, National Heart, Lung, and Blood Institute and Clinical Pathology Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, 20014 Division of Blood Diseases and Resources, National Heart, Lung, and Blood Institute and Clinical Pathology Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, 20014 Meloy Laboratories Inc., 6715 Electronic Drive, Springfield, VA, 22151Search for more papers by this authorR. M. Jaffe, R. M. Jaffe Laboratory of Experimental Atheroslerosis, National Heart, Lung, and Blood Institute and Clinical Pathology Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, 20014 Division of Blood Diseases and Resources, National Heart, Lung, and Blood Institute and Clinical Pathology Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, 20014 Meloy Laboratories Inc., 6715 Electronic Drive, Springfield, VA, 22151Search for more papers by this authorR. W. Mahley, R. W. Mahley Laboratory of Experimental Atheroslerosis, National Heart, Lung, and Blood Institute and Clinical Pathology Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, 20014 Division of Blood Diseases and Resources, National Heart, Lung, and Blood Institute and Clinical Pathology Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, 20014 Meloy Laboratories Inc., 6715 Electronic Drive, Springfield, VA, 22151Search for more papers by this author First published: 01 September 1978 https://doi.org/10.1007/BF02535828 The online version of the original article can be found at http://dx.doi.org/10.1007/BF02533594 AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. Volume13, Issue9September 1978Pages 626-626 RelatedInformation